857119P

06:0 Lyso PA

Avanti Research^™ - A Croda Brand

• Synonyme(s) : 1-hexanoyl-sn-glycero-3-phosphate (ammonium salt); PA(6:0/0:0)
• Formule empirique (notation de Hill): C₉H₂₂NO₇P
• Numéro CAS: 384835-45-4
• Poids moléculaire : 287.25
• Code UNSPSC : 51191904
• Nomenclature NACRES : NA.25

Propriétés

• Description: 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt)
• Pureté: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
• Forme: powder
• Conditionnement: pkg of 1 × 25 mg (857119P-25mg)
• Fabricant/nom de marque: Avanti Research^™ - A Croda Brand
• Type de lipide: cardiolipins; phospholipids
• Conditions d'expédition: dry ice
• Température de stockage: −20°C
• Chaîne SMILES: O[C@](COP([O-])(O)=O)([H])COC(CCCCC)=O.[NH4+]

Description

Description générale

Lysophosphatidic acid (LPA) belongs to a class of phospholipids, that has a glycerol backbone attached by a phosphate group, an aliphatic chain and a hydroxyl group. It has a phosphate group attached to sn-3 position, an aliphatic chain attached to sn-1 or sn-2 position and the hydroxyl group attached to the remaining sn-1 or sn-2 position. 06:0 Lyso PA/HHGP, belongs to the LPA (lysophosphatidic acid) family. It is a negatively charged single chain lipid.

Lysophosphatidic acid (LPA) has a free hydroxyl and phosphate moiety. It is hydrophilic and is not associated with the membrane. It is the major constituent of serum.

Application

06:0 Lyso PA (LPA) has been used in the structure-activity relationship (SAR) analysis with G-protein receptor GPR92. It has also been used in lipid assay in the treatment of serum-starved primary mouse embryonic fibroblast cells.

06:0 Lyso PA has been used to study the role of lipid binding to MxiM protein in co‐crystallization experiments.

Actions biochimiques/physiologiques

Lysophosphatidic acid (LPA) is the precursor for the synthesis of phospholipids in eukaryotes and prokaryotes. It acts as an intercellular signaling molecule. Activated platelets produce LPA. It plays a major role in tissue healing and wound regeneration. LPA binds to G-protein coupled receptors. It possesses mitogenic properties. LPA inhibits differentiation of neuroblastoma and myoblast, aids in neurotransmitter release and smooth muscle contraction. It is a potential biomarker for ovarian and gynecological cancers. It is implicated in the initiation of neuropathic pain.

Lysophosphatidic acid (LPA) participates in several biological functions. LPA stimulates platelet aggregation, chemotaxis, cytoskeleton rearrangement, Ca²⁺ mobilization and cell proliferation. 06:0 Lyso PA/HHGP possesses a micromolar binding affinity for global regulator of LEE (locus of enterocyte effacement) repressor (GrlR) and for β-lactoglobulin.

Conditionnement

5 mL Amber Glass Screw Cap Vial (857119P-25mg)

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informations sur la sécurité

• Code de la classe de stockage: 11 - Combustible Solids